This week, BioNTech - the company which partnered with Pfizer to develop the Covid-19 vaccine that's being used in New Zealand's rollout - announced it would be soon seeking approval for the vaccine to be used in children aged 5-plus, and planned to trial the vaccine in babies aged over 6 months.
Tamariki as young as 12 have been able to receive the vaccine in Aotearoa for more than a month. But with kids outside Auckland having returned to school, and the SuperCity cautiously optimistic about alert level reductions, concerns are circulating about how to keep our youngest Kiwis safe in a world with Delta.
Dr Jin Russell is a developmental paediatrician at Starship Children's Hospital, and PhD student at Auckland University's School of Population Health. She answered subscribers' questions on kids' health and wellbeing in the pandemic in a live chat earlier today. Check out the conversation below, or if you're reading this on our app, tap the speech button at the top of your screen.
